Premium
P3‐376: The impact of acute hospitalization on people with dementia: The behavior and pain (BepAid) study
Author(s) -
Sampson Elizabeth,
Blanchard Martin,
Dening Karen Harrison,
Scott Sharon,
Jones Louise
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.1819
Subject(s) - dementia , medicine , affect (linguistics) , medical prescription , psychiatry , acute hospital , challenging behaviour , antipsychotic , acute care , health care , nursing , psychology , schizophrenia (object oriented programming) , disease , intellectual disability , communication , pathology , economics , economic growth
those receiving one yearly follow up visit and those receiving a 6 months visit to the memory clinics. An assessment of cognitive, functional, quality of life, health economic cost indicators was made at entry and at the end of the study. Linear mixed models with random intercept and slope were used to compare outcomes in both groups. 1. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B; PLASA Group. Effectiveness of a specific care plan inpatients with Alzheimer’s disease: cluster randomised trial (PLASA study). BMJ2010;3;340:c2466. Results: Patients with 6 M (n1⁄4 163) or yearly follow-up (n 1⁄4 251) were quite similar at study entry. The decline in MMSE score at 2 years was less by 1.21 6 0.60 point (p 1⁄4 0.04) in patients with a 6 M follow up than in those with a 12 M follow-up. The yearly hospitalization rate significantly differed (19.8 % for 6 M vs 26.9 %)(p1⁄40.03). The incidence of nursing home entry per year was7.1% vs 10.6% and death 0.7% vs 2.1% by year in favour of the 6 M group but did not reach significance. No differences were found in function as measured by the ADCS-ADL. Health economics expenses were similar in both groups (p1⁄40.98)Conclusions:This is the first study to compare clinical outcomes for memory clinic patients with different follow-up frequencies. Our findings suggest that six month follow-up intervals may provide a clinical benefit over yearly ones by modestly attenuating cognitive decline and possibly reducing hospitalisation in patients with dementia without generating extra costs.